| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: ULAB |
| Security Type |
Common Stock |
| Lead Underwriter |
Credit Suisse First Boston Salomon Smith Barney |
| Days In Registration |
33 |
| Date Filed |
3-May-2001 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Healthcare |
| Business Description |
Own and operate medical laboratories; provide competitively-priced laboratory testing services to physicians, managed care groups, hospitals and other healthcare providers |
| Revenue |
$368.2M |
| Net Income |
$43.1M |
| Shares Outstanding (post-offering) |
33.21M |
| Exe. VP, Sec & Gen. Counsel |
David W. Gee, Esq. |
| Number of Employees |
3600 |
|
| Original Filing Information |
| US |
| Shares Filed |
6.7M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
6.7M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
1005.0K |
| File Amount |
$100.5M |
| File Price Range |
$16.00 - $14.00 |
| File Mid Price |
$15.00 |
Current Filing Information
(Amended 5-Jun-2001) |
|
US |
|
Shares Filed |
6.7M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
6.7M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$100.5M |
| · % Change from Original |
0.0 |
| File Price Range |
$16.00 - $14.00 |
| File Mid Price |
$15.00 |
|
